RNA Aptamers Recognizing Murine CCL17 Inhibit T Cell Chemotaxis and Reduce Contact Hypersensitivity&IT In Vivo&IT

被引:20
作者
Fuellel, Lorenz [1 ]
Steiner, Nancy [1 ]
Funke, Markus [2 ,3 ]
Gondorf, Fabian [1 ]
Pfeiffer, Franziska [2 ,3 ]
Sieg, Julia [2 ,3 ]
Opitz, Friederike V. [1 ]
Hassel, Silvana K. [2 ,3 ]
Erazo, Anna Belen [1 ]
Schanz, Oliver [1 ]
Stunden, H. James [4 ]
Blank, Michael [5 ]
Groeber, Carsten [5 ]
Haendler, Kristian [6 ,7 ,8 ]
Beyer, Marc [6 ,7 ,8 ,9 ]
Weighardt, Heike [1 ]
Latz, Eicke [4 ]
Schultze, Joachim L. [6 ,7 ,8 ]
Mayer, Guenter [2 ,3 ]
Foerster, Irmgard [1 ]
机构
[1] Univ Bonn, Immunol & Environm Life & Med Sci LIMES Inst, Carl Troll Str 31, D-53115 Bonn, Germany
[2] Univ Bonn, Chem Biol & Chem Genet Life & Med Sci LIMES Inst, Gerhard Domagk Str 1, D-53121 Bonn, Germany
[3] Univ Bonn, Ctr Aptamer Res & Dev, Gerhard Domagk Str 1, D-53121 Bonn, Germany
[4] Univ Hosp Bonn, Inst Innate Immun, Sigmund Freud Str 25, D-53127 Bonn, Germany
[5] AptaIT, Klopferspitz 19a, D-82152 Planegg Martinsried, Germany
[6] Univ Bonn, Genom & Immunoregulat Life & Med Sci LIMES Inst, Carl Troll Str 31, D-53115 Bonn, Germany
[7] German Ctr Neurodegenerat Dis DZNE, Platform Single Cell Genom & Epigen, Sigmund Freud Str 27, D-53127 Bonn, Germany
[8] Univ Bonn, Sigmund Freud Str 27, D-53127 Bonn, Germany
[9] German Ctr Neurodegenerat Dis DZNE, Mol Immunol Neurodegenerat, Sigmund Freud Str 27, D-53127 Bonn, Germany
关键词
CHEMOKINE RECEPTOR CCR4; ACTIVATION-REGULATED CHEMOKINE; DENDRITIC CELLS; IMMUNE EVENTS; IN-VIVO; INFLAMMATION; DERMATITIS; LYMPHOMA; LIGANDS; THYMUS;
D O I
10.1016/j.ymthe.2017.10.005
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The chemokine CCL17, mainly produced by dendritic cells (DCs) in the immune system, is involved in the pathogenesis of various inflammatory diseases. As a ligand of CCR4, CCL17 induces chemotaxis and facilitates T cell-DC interactions. We report the identification of two novel RNA aptamers, which were validated in vitro and in vivo for their capability to neutralize CCL17. Both aptamers efficiently inhibited the directed migration of the CCR4(+) lymphoma line BW5147.3 toward CCL17 in a dose-dependent manner. To study the effect of these aptamers in vivo, we used a murine model of contact hyper-sensitivity. Systemic application of the aptamers significantly prevented ear swelling and T cell infiltration into the ears of sensitized mice after challenge with the contact sensitizer. The results of this proof-of-principle study establish aptamers as potent inhibitors of CCL17-mediated chemotaxis. Potentially, CCL17-specific aptamers maybe used therapeutically in humans to treat or prevent allergic and inflammatory diseases.
引用
收藏
页码:95 / 104
页数:10
相关论文
共 56 条
[1]   A strategy to discover decoy chemokine ligands with an anti-inflammatory activity [J].
Abboud, Dayana ;
Daubeuf, Francois ;
Quoc Tuan Do ;
Utard, Valerie ;
Villa, Pascal ;
Haiech, Jacques ;
Bonnet, Dominique ;
Hibert, Marcel ;
Bernard, Philippe ;
Galzi, Jean-Luc ;
Frossard, Nelly .
SCIENTIFIC REPORTS, 2015, 5
[2]   Granulocyte macrophage colony-stimulating factor induces CCL17 pro uction via IRF4 to mediate inflammation [J].
Achuthan, Adrian ;
Cook, Andrew D. ;
Lee, Ming-Chin ;
Saleh, Reem ;
Khiew, Hsu-Wei ;
Chang, Melody W. N. ;
Louis, Cynthia ;
Fleetwood, Andrew J. ;
Lacey, Derek C. ;
Christensen, Anne D. ;
Frye, Ashlee T. ;
Lam, Pui Yeng ;
Kusano, Hitoshi ;
Nomura, Koji ;
Steiner, Nancy ;
Foerster, Irmgard ;
Nutt, Stephen L. ;
Olshansky, Moshe ;
Turner, Stephen J. ;
Hamilton, John A. .
JOURNAL OF CLINICAL INVESTIGATION, 2016, 126 (09) :3453-3466
[3]   Internalization of the chemokine receptor CCR4 can be evoked by orthosteric and allosteric receptor antagonists [J].
Ajram, Laura ;
Begg, Malcolm ;
Slack, Robert ;
Cryan, Jenni ;
Hall, David ;
Hodgson, Simon ;
Ford, Alison ;
Barnes, Ashley ;
Swieboda, Dawid ;
Mousnier, Aurelie ;
Solari, Roberto .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2014, 729 :75-85
[4]   Compartmentalized production of CCL17 in vivo:: Strong inducibility in peripheral dendritic cells contrasts selective absence from the spleen [J].
Alferink, J ;
Lieberam, I ;
Reindl, W ;
Behrens, A ;
Weiss, S ;
Hüser, N ;
Gerauer, K ;
Ross, R ;
Reske-Kunz, AB ;
Ahmad-Nejad, P ;
Wagner, H ;
Förster, I .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (05) :585-599
[5]   Structures of thymus and activation-regulated chemokine (TARC) [J].
Asojo, OA ;
Boulègue, C ;
Hoover, DM ;
Lu, WY ;
Lubkowski, J .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 2003, 59 :1165-1173
[6]   Targeting CCR4 as an emerging strategy for cancer therapy and vaccines [J].
Bayry, Jagadeesh ;
Tartour, Eric ;
Tough, David F. .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2014, 35 (04) :163-165
[7]  
Blank M, 2016, METHODS MOL BIOL, V1380, P85, DOI 10.1007/978-1-4939-3197-2_7
[8]   Aptamer Selection Technology and Recent Advances [J].
Blind, Michael ;
Blank, Michael .
MOLECULAR THERAPY-NUCLEIC ACIDS, 2015, 4 :e223
[9]   Humanization of an Anti-CCR4 Antibody That Kills Cutaneous T-Cell Lymphoma Cells and Abrogates Suppression by T-Regulatory Cells [J].
Chang, De-Kuan ;
Sui, Jianhua ;
Geng, Shusheng ;
Muvaffak, Asli ;
Bai, Mei ;
Fuhlbrigge, Robert C. ;
Lo, Agnes ;
Yammanuru, Anuradha ;
Hubbard, Luke ;
Sheehan, Jared ;
Campbell, James J. ;
Zhu, Quan ;
Kupper, Thomas S. ;
Marasco, Wayne A. .
MOLECULAR CANCER THERAPEUTICS, 2012, 11 (11) :2451-2461
[10]   Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival [J].
Curiel, TJ ;
Coukos, G ;
Zou, LH ;
Alvarez, X ;
Cheng, P ;
Mottram, P ;
Evdemon-Hogan, M ;
Conejo-Garcia, JR ;
Zhang, L ;
Burow, M ;
Zhu, Y ;
Wei, S ;
Kryczek, I ;
Daniel, B ;
Gordon, A ;
Myers, L ;
Lackner, A ;
Disis, ML ;
Knutson, KL ;
Chen, LP ;
Zou, WP .
NATURE MEDICINE, 2004, 10 (09) :942-949